MENU
LXEO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Lexeo Therapeutics (LXEO) Ownership - Who owns Lexeo Therapeutics?
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated... Show more
Profile
Industry
N/A
Address
345 Park Avenue South
Phone
+1 212 547-9879
Employees
58
Web
https://www.lexeotx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
264.07M
P/E Ratio
N/A
Total Cash
132.89M
Projected Growth
N/A
Total Debt
8.91M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
2.46
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
LXEO
Capitalization
264M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
133M
Total Cash/Share
2.46
Total Debt
8.91M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
138M
P/B Ratio
1.90
Cash Flow
N/A
Earnings
-3.21
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
4.43
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-111.97M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-62.04
Shares Held By Institutions
152M
Shares Outstanding - Current
54M
Total Liabilities
37.8M
Total Volume MTD
N/A
Value
-1
Gain YTD
-26.292
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
345 Park Avenue South
Phone
+1 212 547-9879
Employees
58
Web
https://www.lexeotx.com